UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR TransMedics Group, Inc. (Exact name of registrant as specified in its charter) Massachusetts 83-2181531 (State or other jurisdiction of incorporation or organization) 200 Minuteman Road Andover, Massachusetts 01810 (Address of principal executive offices) (Zip code) (I.R.S. Employer ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (978) 552-0900 (Registrant's telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: For the transition period from to Commission File Number: 001-3 ...

Transmedics Group, Inc. (NASDAQ:TMDX) Q1 2021 Earnings Conference Call May 4, 2021 4:30 PM ET Company Participants Lynn Lewis - Gilmartin Group Waleed Hassanein - Founder, MD, CEO, President & Director Stephen Gordon - CFO, Treasurer & Secretary Conference Call Participants Cecilia Furlong - Morgan Stanley William Plovanic - Canaccord Genuity Suraj Kalia - Oppenheimer Operator Good afternoon and welcome to TransMedics' First Quarter 2021 Earnings Conference Call. [Operator Instructions]. I would now like t ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-38891 TransMedics Group, Inc. (Exact name of Registrant as specified in its Charter) Massachusetts 83-2181531 (State or other jurisd ...

TransMedics Group, Inc. (NASDAQ:TMDX) Q4 2020 Earnings Conference Call March 2, 2021 4:30 PM ET Company Participants Lynn Lewis – Investor Relations Waleed Hassanein – President and Chief Executive Officer Stephen Gordon – Chief Financial Officer Conference Call Participants David Lewis – Morgan Stanley Robbie Marcus – JP Morgan Suraj Kalia – Oppenheimer & Company Brian Kennedy – Cowen & Company Operator Ladies and gentlemen, thank you for standing by and welcome to TransMedics Q4 2020 Earnings Conference. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38891 TransMedics Group, Inc. Securities registered pursuant to Section 12(b) of the Act: | Title of each class | Trading Sym ...

TransMedics Group, Inc. (NASDAQ:TMDX) Q3 2020 Earnings Conference Call November 4, 2020 4:30 AM ET Company Participants Brian Johnston – Vice President, Investor Relations- Gilmartin Group Waleed Hassanein – President and Chief Executive Officer Stephen Gordon – Chief Financial Officer Conference Call Participants Cecilia Furlong – Morgan Stanley Allen Gong – J.P. Morgan Suraj Kalia – Oppenheimer & Company Brian Kennedy – Cowen Operator Ladies and gentlemen, thank you for standing by, and welcome to the Tra ...

TransMedics Group, Inc. (NASDAQ:TMDX) Q2 2020 Earnings Conference Call August 5, 2020 4:30 PM ET Company Participants Brian Johnston - Vice President, Investor Relations-Gilmartin Group Waleed Hassanein - President & Chief Executive Officer Stephen Gordon - Chief Financial Officer Conference Call Participants Suraj Kalia - Oppenheimer Josh Jennings - Cowen & Company Operator Good afternoon, everyone. Thank you for standing by and welcome to the TransMedics Q2 2020 Earnings Conference Call. At this time, all ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR TransMedics Group, Inc. (Exact name of registrant as specified in its charter) FORM 10-Q (Mark One) ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38891 (Address of principal executive offices) (Zip ...

TransMedics Group, Inc. (NASDAQ:TMDX) Q1 2020 Earnings Conference Call May 6, 2020 4:30 PM ET Company Participants Brian Johnston – Vice President, Investor Relations-Gilmartin Group Waleed Hassanein – President and Chief Executive Officer Stephen Gordon – Chief Financial Officer Conference Call Participants Robbie Marcus – JPMorgan Bryan Bergin – Cowen Suraj Kalia – Oppenheimer Operator Ladies and gentlemen, thank you for standing by, and welcome to the TransMedics Q1 2020 Earnings Conference Call. At this ...